Page last updated: 2024-09-03

pca 4230 and cyclin d1

pca 4230 has been researched along with cyclin d1 in 1 studies

Compound Research Comparison

Studies
(pca 4230)
Trials
(pca 4230)
Recent Studies (post-2010)
(pca 4230)
Studies
(cyclin d1)
Trials
(cyclin d1)
Recent Studies (post-2010) (cyclin d1)
90010,885705,157

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrés, V; Font de Mora, J; Goukassian, D; Pérez-Roger, I; Sanz-González, SM; Ureña, J1

Other Studies

1 other study(ies) available for pca 4230 and cyclin d1

ArticleYear
Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.
    British journal of pharmacology, 2001, Volume: 132, Issue:7

    Topics: Animals; Carrier Proteins; Cell Cycle Proteins; Cell Division; Cells, Cultured; Cyclin A; Cyclin D1; Dihydropyridines; DNA-Binding Proteins; Dose-Response Relationship, Drug; E2F Transcription Factors; E2F1 Transcription Factor; Humans; Luciferases; Muscle, Smooth, Vascular; Promoter Regions, Genetic; Rats; Rats, Inbred F344; Recombinant Fusion Proteins; Retinoblastoma-Binding Protein 1; S Phase; Signal Transduction; Time Factors; Transcription Factor DP1; Transcription Factors; Tumor Cells, Cultured

2001